Transplantation

African-American Kidneys May Worsen Transplant Outcomes

Jody A. Charnow February 01, 2012

Recipients of kidneys from African Americans (AA) are at increased risk of all-cause and cardiovascular mortality compared with patients who receive kidneys from non-AA donors.

Correcting Anemia Can Protect Renal Allografts

Jody A. Charnow January 31, 2012

Targeting hemoglobin (Hb) values of 13 g/dL or higher reduces progression of chronic allograft nephropathy in kidney-transplant recipients, a prospective study suggests.

Risk Factors for Transplant-Related Urinary Complications Characterized

Rosemary Frei, MSc January 26, 2012

MIAMI BEACH, Fla.—A review of 635 kidney transplants performed at the University of Florida, Gainesville, has confirmed that transplanted kidneys with more than one renal artery put recipients at increased risk for urinary complications.

Online Tools Increase Efficiency, Speed of Kidney Donor Screening

Rosemary Frei, MSc January 25, 2012

MIAMI BEACH, Fla.—Using web-based preliminary screening of potential kidney donors has resulted in a flood of applications at two U.S. transplant centers.

Stents May Benefit Renal Transplant Patients

Jody A. Charnow January 24, 2012

Ureteral stents in recipients of deceased donor organs lower the risk of ureteral complications.

Deceased Donor Transplantation Rates Declining

Jody A. Charnow January 13, 2012

Dialysis patients waiting for a deceased donor kidney transplant face a declining likelihood of receiving one, according to a recent study.

Black Race Worsens Transplant Outcomes

Jody A. Charnow January 04, 2012

Black race is associated with worse renal transplant outcomes among patients with lupus nephritis and focal segmental glomerulosclerosis (FSGS), according to two studies presented at Kidney Week, the annual meeting of the American Society of Nephrology.

Correcting Anemia Reduces Odds of Renal Transplant Failure

December 29, 2011

Complete correction of anemia (hemoglobin, 13 g/dL or higher) in kidney transplant recipients slows progression to chronic allograft nephropathy, a study found.

Transplant Outcomes Unaffected by High-Dose Erythropoietin

Jody A. Charnow November 30, 2011

High-dose erythropoietin has no significant effect on short- or long-term graft function in renal transplant patients who had chronic kidney disease (CKD) after receiving a deceased donor organ, according to a new study.

Black Transplant Patients with FSGS Are At Higher Risk

Jody A. Charnow November 12, 2011

PHILADELPHIA—Among kidney transplant recipients with focal segmental glomerulosclerosis (FSGS), African-Americans (AA) have a greater prevalence of risk factors for allograft failure compared with other races, according to findings presented at Kidney Week 2011.

High Pretransplant Phosphorus Raises Post-Transplant Death Risk

Jody A. Charnow November 12, 2011

PHILADELPHIA—High pre-transplant serum phosphorus levels are associated with worse outcomes following renal transplantation, according to study findings presented at Kidney Week 2011.

Live Kidney Donation Raises Hypertension Risk in Blacks

Jody A. Charnow November 12, 2011

PHILADELPHIA—Live kidney donation by African-Americans increases their risk of hypertension, researchers reported at Kidney Week 2011.

Depressive Symptoms after Kidney Transplantation Are Associated with Decreased Survival

Jody A. Charnow November 12, 2011

In a study presented at Kidney Week of 527 renal transplant recipients who had a median follow-up of seven years, researchers Dorien M. Zelle, MD, and colleagues at the University Medical Center Groningen in Groningen, the Netherlands, demonstrated that subjects who experienced depression following transplantation had an increased risk of death.

Acute Rejection Risk Higher with Membranous Glomerulonephritis

Jody A. Charnow November 11, 2011

PHILADELPHIA—Membranous glomerulonephritis (GN) is the most common form of primary GN associated with acute renal allograft rejection following renal transplantation, researchers reported at Kidney Week 2011.

Pretransplant ESA Hyporesponsiveness May Worsen Post-Transplant Outcomes

Jody A. Charnow November 11, 2011

PHILADELPHIA—Two research teams have found that hyporesponsiveness to erythropoiesis stimulating agents (ESAs) prior to renal transplantation is associated with a higher risk of post-transplant allograft failure and mortality, according to study findings presented at Kidney Week 2011.

Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus. (ADHERE)

Light for Renal Transplant Recipients Having a Sleep-Wake Dysregulation (SleepTx-1)

Our exclusive coverage of Kidney Week 2011 in Philadelphia includes interviews, videos and noteworthy clinical reports.

Sections: Anemia | Transplantation
Secondary Hyperparathyroidism | General News
More: Videos

On The Forefront

Boosting Renal Transplantation with Kidney Paired Donation

In the past five to 10 years, researchers have developed several techniques to overcome donor incompatibility, including paired donation. The following case illustrates the collaborative efforts between nephrologists and urologists at the Glickman Urological and Kidney Institute.

Latest CME Article

Renal & Urology News includes a CME article in every print issue, which will also be available online.

View the latest installment:

An Update on Robotic-Assisted Partial Nephrectomy

CME SPOTLIGHT

Androgen Deprivation Therapy in Prostate Cancer: Addressing Clinical Challenges
1.00 / AMA PRA Category 1 Credit(s)™ Click here for more courses